The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.

Onco Targets Ther · 2017 · PMC5530847 · PMID 28790848

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Interestingly, comparing patients with stage IIIB disease, significant decreases in serum concentrations of Trp ( P =0.018) and increases in IDO activity ( P =0.012) were found in patients with stage IV disease, whereas the Kyn concentration did not reach statistical significance ( Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.